Voûte Pa
- Pulmonary and Respiratory Medicine top 10%
- Molecular Biology
- Surgery
- Neurology top 10%
- Pathology and Forensic Medicine
- Topics
- Neuroblastoma Research and Treatments (10 papers)Sarcoma Diagnosis and Treatment (10 papers)Renal and related cancers (5 papers)
- Partner nations
- NetherlandsGermanyAustria
In The Last Decade
Voûte Pa
39 papers receiving 485 citations
Peers
Comparison fields: 5 of 47
- Pulmonary and Respiratory Medicine 294
- Molecular Biology 173
- Surgery 162
- Neurology 117
- Pathology and Forensic Medicine 91
Countries citing papers authored by Voûte Pa
This map shows the geographic impact of Voûte Pa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Voûte Pa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Voûte Pa more than expected).
Fields of papers citing papers by Voûte Pa
This network shows the impact of papers produced by Voûte Pa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Voûte Pa. The network helps show where Voûte Pa may publish in the future.
Co-authorship network of co-authors of Voûte Pa
This figure shows the co-authorship network connecting the top 25 collaborators of Voûte Pa. A scholar is included among the top collaborators of Voûte Pa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Voûte Pa. Voûte Pa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 15 | |
| 2 | 17 | |
| 3 | 5 | |
| 4 | 49 | |
| 5 | 57 | |
| 6 | A constitutional balanced 1;17 neuroblastoma translocation | 1 |
| 7 | 18 | |
| 8 | 11 | |
| 9 | Chromosome 1p allelic loss in neuroblastoma: prognosis, genomic imprinting and 1;17 translocations. | 5 |
| 10 | 19 | |
| 11 | [A patient with an immunodeficiency and consecutively 3 primary malignancies]. | 1 |
| 12 | 21 | |
| 13 | [Diagnosis and therapy of neural crest tumors using I131 iodobenzylguanidine]. | 2 |
| 14 | 39 | |
| 15 | [Treatment of orbital rhabdomyosarcoma]. | 4 |
| 16 | Total-body scintigraphy with 131I-meta-iodobenzylguanidine for detection of neuroblastoma. | 28 |
| 17 | Phase II study of cisplatin in advanced osteogenic sarcoma. European Organization for Research on Treatment of Cancer Soft Tissue and Bone Sarcoma Group. | 18 |
| 18 | Preoperative chemotherapy in Wilms' tumour. Results of clinical trials and studies on nephroblastomas conducted by the International Society of Paediatric Oncology (SIOP). | 5 |
| 19 | [The treatment of Wilm's tumor, improvements and new trends. A study of 724 cases treated at the Gustave-Roussy Institute. 1952-1980 (author's transl)]. | 1 |
| 20 | Hypercalcemia and elevated parathyroid hormone levels in association with nephroblastoma. | 5 |
About Voûte Pa
Voûte Pa is a scholar working on Neurology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 39 papers that have together received 498 indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (10 papers), Sarcoma Diagnosis and Treatment (10 papers) and Renal and related cancers (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (294 citations), Neurology (117 citations) and Pathology and Forensic Medicine (91 citations). Voûte Pa has collaborated with scholars based in Netherlands, Germany and Austria. Frequent co-authors include Jan de Kraker, U. Göbel, K. Winkler, J. Otten, D Olive, J. Treuner, JM Zucker, M Brunat-Mentigny, F Flamant and Jürgen Dunst. Their work appears in journals such as Cancer, European Journal of Cancer and Advances in experimental medicine and biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.